Drugs / MCV-AC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02003495 Comparator | Oct 2013 → Aug 2014 | meningitis | Beijing Minhai Biotechnology Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCV-AC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02003495 ↗ |
| Modality | Vaccine | “Group A and C Meningococcal conjugate vaccine” NCT02003495 ↗ |
| Route | Intramuscular | “0.5ml, intramuscular” NCT02003495 ↗ |